Increasing Adherence to Atrial Fibrillation Treatment Guidelines
A quality improvement program significantly increased the proportion of patients who were appropriately prescribed blood thinners for atrial fibrillation at hospital discharge.
Browsing: Clinical Breakthroughs
Rewriting Cardiovascular Care Guidelines
Northwestern faculty translate cardiovascular discoveries into clinical guidelines for the nation.
Calling for a Closer Look at Penicillin Allergies
Most patients who report a penicillin allergy are in fact not allergic, and verifying allergies before resorting to less-effective antibiotics can improve outcomes and avoid the spread of antimicrobial resistance, according to a review in JAMA.
Assessing the Benefits of Primary Care
Americans with primary care received significantly more high-value care and reported better patient experience and healthcare access, compared to those without primary care, according to a study published in JAMA Internal Medicine.
Stem Cell Transplants Improve on Current MS Treatments
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
Measuring the Overuse of Outpatient Antibiotics
A new study published in The BMJ illustrates the scale of inappropriate antibiotic prescribing in the U.S. outpatient setting, with the most comprehensive estimates to date.
Full-Body Scan Could Improve Chemotherapy Effectiveness
A new full-body scan could help clinicians better assess patients during cancer treatment, according to a recent study.
Inhaled Nitrite Fails to Show Benefit in Heart Failure; Automated Cardiac Imaging Shows Promise
A treatment of inhaled inorganic nitrite did not improve exercise capacity among patients with a common form of heart failure, according to a clinical trial published in JAMA.
Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.